PAQR4 and liver disorder: PAQR4 regulates adipose ceramide levels; the dysregulation of PAQR4 leads to an accumulation of lipotoxic ceramide species, particularly long-chain ceramides [58,86], correlated with the increased risks of developing metabolic and hepatic diseases [58,86].